Fetal pharmacotherapy 4: fetal thyroid disorders.
The Motherisk Program, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON.
Shirin
S
Namouz-Haddad
The Motherisk Program, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON.
Gideon
G
Koren
D000653:Amniotic Fluid; D003937:Diagnosis, Differential; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D006042:Goiter / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000196:embryology; D006801:Humans; D006980:Hyperthyroidism / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000196:embryology; D007037:Hypothyroidism / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000196:embryology; D011247:Pregnancy; D011441:Propylthiouracil / Q000008:administration & dosage; D013959:Thyroid Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000196:embryology*; D013974:Thyroxine / Q000008:administration & dosage; D016216:Ultrasonography, Prenatal
D011441:Propylthiouracil; D013974:Thyroxine